Vietnam Drugs Market Unfazed By WTO Norms For Openness
This article was originally published in PharmAsia News
Executive SummaryAlthough compliance with World Trade Organization norms has meant a more open pharmaceutical market for Vietnam, the country's drug makers are not concerned about the competition. Among the leading retail firms are Phytopharma, Sapharco and Vimedimex, none of whom shows concern about the possible competition. The head of Phytopharma notes the drugs markets are specialized and local businesses have an advantage when it comes to importing or exporting in a particular country such as Vietnam. (Click here for more
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.